Predicting side effects in older adults with head and neck cancer
Part of Cancer clinical trials.
This trial studies how to predict side effects (toxicity) in older adults (70+) with advanced head and neck cancer. It tests standard treatments like radiation, chemoradiation, or radiation with cetuximab and aims to help doctors tailor care to reduce harm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older.
- You have a type of head and neck cancer called squamous cell or undifferentiated cancer, stage III or IV.
- You are planning to have radiation, radiation with chemotherapy, or radiation with a targeted drug (cetuximab) as treatment.
- You have not had another cancer in the last 2 years, except for very early prostate cancer, early bladder cancer, non-melanoma skin cancer, or cervical cancer in situ.
- You have not received chemotherapy or other systemic treatments for a previous cancer.
- You are willing to sign a consent form and have adequate organ function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This study looks at patients with advanced head and neck cancer who had surgery (with flap reconstruction) and then radiation, with or without chemo. It aims to find what might predict severe side effects or flap failure, which could help tailor future treatments.
This trial tests a new way to give radiation therapy for head and neck cancer. By using a special PET scan to guide where higher radiation doses are given, doctors hope to improve treatment while reducing side effects. It is for people whose cancer is not early-stage and who will receive standard radiation therapy.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This study looks at how outcomes may be predicted for people with head and neck cancer who receive radiotherapy. It may help doctors better estimate results and tailor follow-up care.
This trial tests a nurse-led program to help manage symptoms before they start, for people with head and neck cancer who are getting radiation therapy. The goal is to improve quality of life during treatment.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.